MedTrace Logo

A Study of Acne Treatment in Children Ages 9 to 11

NCT00907335 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2012-02-15

Study results available
· View outcomes & findings →

Summary

A study to determine if using Retin-A Micro 0.04% as facial acne treatment in patients ages 9 to 11 is safe and efficacious.

Conditions

  • Acne Vulgaris

Interventions

DRUG

Retin-A Micro 0.04% facial acne treatment

Retin-A Micro 0.04% facial acne treatment used once daily

DRUG

Vehicle control

Color-matched facial gel vehicle control used once daily

Sponsors & Collaborators

  • Bausch Health Americas, Inc.

    lead INDUSTRY

Principal Investigators

  • Ana Rossi, MD · Johnson & Johnson Consumer and Personal Products Worldwide

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
9 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00907335 on ClinicalTrials.gov